Organic Sales and Operating Profit Growth
The group achieved an organic sales growth of 3% and an organic operating profit increase of 7%, with a group margin of 19.3%, 70 basis points higher organically.
Strong Demand in Biopharm and Semicon
Biopharm orders grew over 10%, supporting strong demand alongside double-digit growth in semicon demand.
Successful Restructuring Efforts
The restructuring program is on track to deliver annual savings of GBP 35 million, improving cash conversion to 61%.
Double-Digit Growth in ETS
ETS achieved 10% organic growth, with significant improvements in process heating and semicon demand.
Strategic MRO and Solutions Sales Growth
STS and Watson-Marlow experienced strong MRO and solutions sales growth, with Watson-Marlow orders exceeding sales, supporting future growth.